XML 14 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Oct. 31, 2025
Oct. 31, 2024
Cash flows from operating activities:    
Net income $ 14,079 $ 10,751
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 7,039 6,960
Transactional losses 1,685 594
Provision for inventories and accounts receivable 4,282 4,489
Deferred income taxes (708) (1,582)
Stock-based compensation 3,525 4,094
Other 741 265
Changes in assets and liabilities:    
Trade receivables (17,823) (30,220)
Inventories (28,250) (26,031)
Other current assets 4,014 (4,675)
Accounts payable (9,314) (3,709)
Accrued liabilities 14,868 11,224
Accrued payroll and benefits 7,508 2,369
Income taxes receivable 2,216 8,982
Income taxes payable (3,938) (20,954)
Other non-current assets 1,224 (3,141)
Other non-current liabilities 118 (43)
Net cash provided by/(used in) operating activities 1,266 (40,627)
Cash flows from investing activities:    
Capital expenditures (3,512) (6,368)
Long-term investments (2,727) (5,467)
Trademarks and other intangibles (58) (86)
Net cash used in investing activities (6,297) (11,921)
Cash flows from financing activities:    
Dividends paid (23,306) (23,319)
Stock repurchases (1,594) (2,628)
Stock awards and options exercised and other changes (474) (1,101)
Net cash used in financing activities (25,374) (27,048)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 5,875 (917)
Net decrease in cash, cash equivalents and restricted cash (24,530) (80,513)
Cash, cash equivalents, and restricted cash at beginning of year 209,214 262,814
Cash, cash equivalents, and restricted cash at end of period 184,684 182,301
Reconciliation of cash, cash equivalents, and restricted cash:    
Cash and cash equivalents 183,876 181,548
Restricted cash included in other non-current assets 808 753
Cash, cash equivalents, and restricted cash at end of period $ 184,684 $ 182,301